Sernova Biotherapeutics Inc
SVA.TO
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.58M | -2.97M | -2.66M | -4.01M | -3.64M |
| Total Depreciation and Amortization | 44.80K | 134.70K | 33.50K | 33.50K | 124.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 707.30K | 334.90K | 427.70K | 497.70K | -427.10K |
| Change in Net Operating Assets | 708.00K | 987.20K | -503.60K | 79.70K | 1.07M |
| Cash from Operations | -123.30K | -1.51M | -2.70M | -3.40M | -2.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 14.50K | 3.50K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | 14.50K | 3.50K | -- | -- | 0.00 |
| Total Debt Issued | 90.50K | 173.70K | 4.67M | -- | -- |
| Total Debt Repaid | -6.80K | -20.30K | -43.30K | -42.50K | -42.00K |
| Issuance of Common Stock | 266.90K | -- | -- | -- | 5.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.20K | 0.00 | 0.00 | 64.80K | -253.50K |
| Cash from Financing | 239.50K | 111.70K | 3.26M | 15.70K | 3.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.70K | -1.39M | 555.90K | -3.38M | 727.30K |